Pregnancy outcomes of non-tumour necrosis factor inhibitor biologic disease-modifying antirheumatic drugs among individuals with autoimmune diseases: a scoping review and proposed framework for reporting outcomes

ABSTRACT: Objectives: Biologic disease-modifying antirheumatic drugs (bDMARDs) have transformed autoimmune disease treatment. Although the perinatal impacts of tumour necrosis factor inhibitors (TNFis) have been systematically synthesised, comparable evidence syntheses for non-TNFi bDMARDs are lack...

Descripción completa

Detalles Bibliográficos

Autores principales:	Vienna Cheng, Neda Amiri, Vicki Cheng, Ursula Ellis, Jacquelyn J. Cragg, Laurie Proulx, Mary A. De Vera
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-10-01
Colección:	EULAR Rheumatology Open
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S3050708125000540
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!